Preliminary evidence for the importance of therapeutic alliance in MDMA-assisted psychotherapy for posttraumatic stress disorder
European Journal of Psychotraumatology · 2024
DOI: 10.1080/20008066.2023.2297536 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift European Journal of Psychotraumatology, 2024. Verfasst von Richard J Zeifman und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, NYU Grossman School of Medicine, NYU Langone Centre for Psychedelic Medicine, New York, NY, USA. Hauptthemen laut MEDLINE: N-Methyl-3,4-methylenedioxyamphetamine, Stress Disorders, Post-Traumatic, Therapeutic Alliance. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Canadian Institutes of Health Research, MAPS Public Benefit Corporation.
Abstract (Originalsprache)
Background
MDMA-assisted psychotherapy (MDMA-AP) is a combined psychotherapeutic and pharmacologic intervention that shows promise in the treatment of posttraumatic stress disorder (PTSD). Although therapeutic alliance has been established as a key predictor across psychotherapies and is emphasised within MDMA-AP treatment manuals, research has not yet examined the relationship between therapeutic alliance and MDMA-AP treatment outcomes.
Objective
Examine whether therapeutic alliance predicts changes in PTSD symptoms following MDMA-AP.
Method
Twenty-three individuals with chronic PTSD participated in a MDMA-AP clinical trial that included a randomised (MDMA vs. placebo) and open-label phase. The present analyses focused on participants who were administered MDMA over the course of the randomised and open-label phases (n = 22). Therapeutic alliance was assessed using the Working Alliance Inventory at sessions baseline (pre-session 3) and sessions 4 and 9. PTSD symptoms were assessed using the Clinician Administered PTSD Scale and the Impact of Events Scale-Revised.
Results
Controlling for baseline clinician-assessed PTSD severity, therapeutic alliance at sessions 4 and 9 (but not baseline) significantly predicted post-MDMA-AP clinician-assessed PTSD severity. Controlling for baseline self-reported PTSD severity, therapeutic alliance at baseline (although this did not survive correction for multiple comparisons) and sessions 4 and 9 predicted post-MDMA-AP self-reported PTSD severity.
Conclusions
The present results provide the first preliminary evidence for the relationship between the therapeutic alliance and treatment outcomes within MDMA-AP for PTSD. These findings highlight the important role of psychotherapy, and common psychotherapeutic factors, within MDMA-AP. Replication in studies with larger and more diverse clinical samples remain necessary.
Trial registration
ClinicalTrials.gov identifier: NCT00090064. Among individuals with chronic posttraumatic stress disorder, therapeutic alliance predicted changes in posttraumatic stress disorder severity following MDMA-assisted psychotherapy.Therapeutic alliance may play a key role in facilitating therapeutic improvement within MDMA-assisted psychotherapy.Further research remains necessary to confirm these preliminary findings and the role of therapeutic alliance in MDMA-assisted psychotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry, NYU Grossman School of Medicine, NYU Langone Centre for Psychedelic Medicine, New York, NY, USA.
- Centre for Psychedelic Research, Department of Brain Sciences, Faculty of Medicine, Imperial College London, London, UK.
- MAPS Public Benefit Corporation (MPBC), San Jose, CA, USA.
- Department of Psychology, Toronto Metropolitan University, Toronto, Canada.
Förderung
- Canadian Institutes of Health Research
- MAPS Public Benefit Corporation
Zitieren
APA
Zeifman, R. J., Kettner, H., Ross, S., Weiss, B., Mithoefer, M. C., Mithoefer, A. T., & Wagner, A. C. (2024). Preliminary evidence for the importance of therapeutic alliance in MDMA-assisted psychotherapy for posttraumatic stress disorder. European Journal of Psychotraumatology. https://doi.org/10.1080/20008066.2023.2297536
Vancouver
Zeifman RJ, Kettner H, Ross S, Weiss B, Mithoefer MC, Mithoefer AT, et al. Preliminary evidence for the importance of therapeutic alliance in MDMA-assisted psychotherapy for posttraumatic stress disorder. European Journal of Psychotraumatology. 2024. doi:10.1080/20008066.2023.2297536
BibTeX
@article{Zeifman2024,
author = {Zeifman, Richard J and Kettner, Hannes and Ross, Stephen and Weiss, Brandon and Mithoefer, Michael C and Mithoefer, Ann T and Wagner, Anne C},
title = {Preliminary evidence for the importance of therapeutic alliance in MDMA-assisted psychotherapy for posttraumatic stress disorder},
journal = {European Journal of Psychotraumatology},
year = {2024},
doi = {10.1080/20008066.2023.2297536}
}
EUVIMED